MRI-Derived Pancreatic Fat Fraction Is Independently Associated with Intraductal Papillary Mucinous Neoplasms: A

Sedat Çiçek1, Delyadil Karakaş Kılıç2, Selman Çetin1

  • 1Department of Gastroenterology, Fırat University, Elazig 23119, Türkiye.

Insights

Increased pancreatic fat fraction, measured by MRI, is strongly associated with intraductal papillary mucinous neoplasms (IPMN). This quantitative assessment shows promise as a biomarker for detecting IPMN, a precursor to pancreatic cancer.

Area of Science:

  • Gastroenterology
  • Radiology
  • Oncology

Background:

  • Intraductal papillary mucinous neoplasms (IPMNs) are recognized as precancerous lesions of the pancreas.
  • Early detection of IPMNs is crucial for preventing pancreatic cancer progression.

Purpose of the Study:

  • To investigate the association between MRI-derived pancreatic fat fraction and the presence of IPMN.
  • To evaluate the diagnostic performance of pancreatic fat fraction in distinguishing IPMN from non-IPMN individuals.

Main Methods:

  • A retrospective case-control study involving 60 IPMN patients and 120 controls.
  • Pancreatic MRI with proton density fat fraction (PDFF) imaging was utilized.
  • Pancreatic fat fraction was quantified in different pancreatic regions and a mean value was calculated.

Main Results:

  • Patients with IPMN were older and exhibited distinct biochemical profiles compared to controls.
  • Significantly elevated pancreatic fat fraction was observed in all pancreatic regions for the IPMN group.
  • Mean pancreatic fat fraction demonstrated excellent diagnostic performance (AUC = 0.968) for IPMN detection.

Conclusions:

  • Pancreatic fat fraction is significantly higher in individuals with IPMN.
  • MRI-derived pancreatic fat fraction is an independent predictor of IPMN presence.
  • Quantitative assessment of pancreatic fat fraction using MRI serves as a valuable imaging biomarker for IPMN detection.

Related Concept Videos